Yoshida Tatsuya 吉田達哉

… Alternative Names

吉田達哉ヨシダタツヤ

Less

Researcher Number	10729338
External Links
Affiliation (Current)	2025: 国立研究開発法人国立がん研究センター, 中央病院, 医長
Affiliation (based on the past Project Information) *help	2023: 国立研究開発法人国立がん研究センター, 中央病院, 医長 2021 – 2022: 国立研究開発法人国立がん研究センター, 中央病院, 医員 2015 – 2016: 愛知県がんセンター(研究所), 分子腫瘍学部, 研究員
Review Section/Research Field	Principal Investigator Basic Section 53030:Respiratory medicine-related / Basic Section 50020:Tumor diagnostics and therapeutics-related / Medical sociology Except Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 49020:Human pathology-related
Keywords	Principal Investigator 免疫チェックポイント阻害剤 / 肺癌 / 免疫療法 / 小細胞肺癌 / 神経内分泌分化 / 小細胞肺がん / 急性炎症性蛋白 / 腫瘍免疫 / 炎症性サイトカイン / 免疫老化 … More / 腫瘍免疫応答 / 胸部悪性腫瘍 / 急性炎症 / 悪液質 / QOL / 就労支援 / がん … More Except Principal Investigator 抗体医薬による輸注反応（IRR) / 抗体薬物複合体 / サイトカインプロファイル / 新規抗体医薬 / サイトカイン / IRR / がん新薬早期開発 / AI病理学 / デジタル病理学 / 病理組織 / 治療効果予測 / 形態学的バイオマーカー Less

SCLC subtyping as a predictor of therapeutic response to immunotherapyPrincipal Investigator
- Principal Investigator
  
  吉田達哉
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  National Cancer Center Japan
進行癌に対する次世代抗体薬投与時サイトカインプロファイル緊急網羅的解析モデル探索
- Principal Investigator
  
  清水俊雄
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Wakayama Medical University
Development study on pathological predictive biomarkers for cancer treatment
- Principal Investigator
  
  元井紀子
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 49020:Human pathology-related
- Research Institution
  Research Institute for Clinical Oncology Saitama Cancer Center
Acute phase protein and cachexia on adaptive immunity in thoracic malignancyPrincipal Investigator
- Principal Investigator
  
  Yoshida Tatsuya
- Project Period (FY)
  2021 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  National Cancer Center Japan
進行期肺癌患者の就労支援、およびその阻害因子の同定に関する研究Principal Investigator
- Principal Investigator
  
  吉田達哉
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical sociology
- Research Institution
  Aichi Cancer Center Research Institute

All 2024 2023 2022 2021 2017 2016 2015

All Journal Article Presentation

[Journal Article] Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer2024
- Author(s)
  Ohashi Kana、Nishito Yukari、Fukuda Hironori、Sadahiro Ryoichi、Yoshida Yukihiro、Watanabe Shun-ichi、Motoi Noriko、Sonobe Yukiko、Mizuno Hideaki、Tsunoda Hiroyuki、Tatsumi Koichiro、Suzuki Takuji、Ochiai Atsushi、Aoki Kazunori
- Journal Title
  
  Scientific Reports
  
  Volume: 14 Issue: 1
- DOI
  10.1038/s41598-023-50378-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06900
[Journal Article] An algorithm-based technique for counting mitochondria in cells using immunohistochemical staining of formalin-fixed and paraffin-embedded sections2024
- Author(s)
  Sakashita Mai、Motoi Noriko、Yamamoto Gaku、Gambe Emi、Suzuki Masanori、Yoshida Yukihiro、Watanabe Shun-ichi、Takazawa Yutaka、Aoki Kazunori、Ochiai Atsushi、Sakashita Shingo
- Journal Title
  
  Journal of Cancer Research and Clinical Oncology
  
  Volume: 150 Issue: 4
- DOI
  10.1007/s00432-024-05653-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06899, KAKENHI-PROJECT-21K06900
[Journal Article] Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth: A Proposal by the International Association for the Study of Lung Cancer Pathology Committee2023
- Author(s)
  Thunnissen Erik、Beasley Mary Beth、Borczuk Alain、Dacic Sanja、Kerr Keith M.、Lissenberg-Witte Birgit、Minami Yuko、Nicholson Andrew G.、Noguchi Masayuki、Sholl Lynette、Tsao Ming-Sound、Le Quesne John、Roden Anja C.、Chung Jin-Haeng、Yoshida Akihiko、Moreira Andre L.、et al. Motoi Noriko、et al.
- Journal Title
  
  Journal of Thoracic Oncology
  
  Volume: 18 Issue: 4 Pages: 447-462
- DOI
  10.1016/j.jtho.2022.11.026
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K06900, KAKENHI-PROJECT-20H03461, KAKENHI-PROJECT-23K27389
[Journal Article] Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy2023
- Author(s)
  Shirasawa Masayuki、Yoshida Tatsuya、Shiraishi Kouya、et al.
- Journal Title
  
  Lung Cancer
  
  Volume: 179 Pages: 107183-107183
- DOI
  10.1016/j.lungcan.2023.107183
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20H03695, KAKENHI-PROJECT-21K19492, KAKENHI-PROJECT-23K07615, KAKENHI-PROJECT-20K17668
[Journal Article] Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer2023
- Author(s)
  Shirasawa Masayuki、Yoshida Tatsuya、Shiraishi Kouya、Yagihita Shigehiro、Ohe Yuichiro et al.
- Journal Title
  
  British Journal of Cancer
  
  Volume: 129 Issue: 12 Pages: 2003-2013
- DOI
  10.1038/s41416-023-02427-3
- Data Source
  KAKENHI-PROJECT-23K07615
[Journal Article] Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study2023
- Author(s)
  Paz-Ares Luis、Champiat Stephane、Yoshida Tatsuya、et al.
- Journal Title
  
  Journal of Clinical Oncology
  
  Volume: 41 Issue: 16 Pages: 2893-2903
- DOI
  10.1200/jco.22.02823
- Data Source
  KAKENHI-PROJECT-23K07615
[Journal Article] Prognostic role of modified Glasgow Prognostic score in elderly non-small cell lung cancer patients treated with anti-PD-1 antibodies2023
- Author(s)
  Tanaka Tomohiro、Yoshida Tatsuya、Masuda Ken、Takeyasu Yuki、Shinno Yuki、Matsumoto Yuji、Okuma Yusuke、Goto Yasushi、Horinouchi Hidehito、Yamamoto Noboru、Ohe Yuichiro
- Journal Title
  
  Respiratory Investigation
  
  Volume: 61 Issue: 1 Pages: 74-81
- DOI
  10.1016/j.resinv.2022.10.003
- Data Source
  KAKENHI-PROJECT-21K15584
[Journal Article] Clinical Characteristics and Pharmacokinetics Change of Long-Term Responders to Antiprogrammed Cell Death Protein 1 Inhibitor Among Patients With Advanced NSCLC2023
- Author(s)
  Jo Hitomi、Yoshida Tatsuya、Yagishita Shigehiro、Ohuchi Mayu、Matsumoto Yuji、Shinno Yuki、Okuma Yusuke、Goto Yasushi、Horinouchi Hidehito、Yamamoto Noboru、Takahashi Kazuhisa、Motoi Noriko、Hamada Akinobu、Ohe Yuichiro
- Journal Title
  
  JTO Clinical and Research Reports
  
  Volume: 4 Issue: 4 Pages: 100474-100474
- DOI
  10.1016/j.jtocrr.2023.100474
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06900
[Journal Article] Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma2023
- Author(s)
  Higashiyama Masahiro、Motoi Noriko、Yotsukura Masaya、Yoshida Yukihiro、Nakagawa Kazuo、Yagishita Shigehiro、Shirasawa Masayuki、Yoshida Tatsuya、Shiraishi Kouya、Kohno Takashi、Ohe Yuichiro、Watanabe Shun‐ichi
- Journal Title
  
  Pathology International
  
  Volume: 73 Issue: 5 Pages: 188-197
- DOI
  10.1111/pin.13316
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06900, KAKENHI-PROJECT-20H03695, KAKENHI-PROJECT-21K19492, KAKENHI-PROJECT-20H00545
[Journal Article] Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients2022
- Author(s)
  Ohuchi Mayu、Yagishita Shigehiro、Jo Hitomi、Akagi Kazumasa、Inaba Higashiyama Ryoko、Masuda Ken、Shinno Yuki、Okuma Yusuke、Yoshida Tatsuya、Goto Yasushi、Horinouchi Hidehito、Makino Yoshinori、Yamamoto Noboru、Ohe Yuichiro、Hamada Akinobu
- Journal Title
  
  Lung Cancer
  
  Volume: 173 Pages: 35-42
- DOI
  10.1016/j.lungcan.2022.08.018
- Data Source
  KAKENHI-PROJECT-21K15584
[Journal Article] Safety Implications of Switching Pembrolizumab Dosage From 200 mg Every 3 Weeks to 400 mg Every 6 Weeks in Patients With Advanced NSCLC2022
- Author(s)
  Higashiyama Ryoko Inaba、Yoshida Tatsuya、Yagishita Shigehiro、Ohuchi Mayu、Sakiyama Naomi、Torasawa Masahiro、Shirasawa Masayuki、Masuda Ken、Shinno Yuki、Matsumoto Yuji、Okuma Yusuke、Goto Yasushi、Horinouchi Hidehito、Yamamoto Noboru、Hamada Akinobu、Ohe Yuichiro
- Journal Title
  
  Journal of Thoracic Oncology
  
  Volume: 17 Issue: 10 Pages: 1227-1232
- DOI
  10.1016/j.jtho.2022.06.010
- Data Source
  KAKENHI-PROJECT-21K15584
[Journal Article] Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients2022
- Author(s)
  Shimoda Yukiko、Shibaki Ryota、Yoshida Tatsuya、Murakami Shuji、Shirasawa Masayuki、Torasawa Masahiro、Matsumoto Yuji、Masuda Ken、Shinno Yuki、Okuma Yusuke、Goto Yasushi、Horinouchi Hidehito、Yamamoto Noboru、Ohe Yuichiro、Motoi Noriko
- Journal Title
  
  Clinical Lung Cancer
  
  Volume: 23 Issue: 6 Pages: 477-486
- DOI
  10.1016/j.cllc.2022.04.001
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K06900
[Journal Article] Correlation between body mass index and efficacy of anti-PD-1 inhibitor in patients with non-small cell lung cancer2022
- Author(s)
  Tateishi Akiko、Horinouchi Hidehito、Yoshida Tatsuya、Masuda Ken、Jo Hitomi、Shinno Yuki、Okuma Yusuke、Goto Yasushi、Yamamoto Noboru、Ohe Yuichiro
- Journal Title
  
  Respiratory Investigation
  
  Volume: 60 Issue: 2 Pages: 234-240
- DOI
  10.1016/j.resinv.2021.11.003
- Data Source
  KAKENHI-PROJECT-21K15584
[Journal Article] “Real” Tumor-Spread Through Air Spaces of Lung Adenocarcinoma Presented Intrapulmonary Metastases Through Bronchiole Air Spaces: A Case Report2022
- Author(s)
  Kaku Sawako、Motoi Noriko、Watanabe Hirokazu、Yoshida Yukihiro、Watanabe Shun-ichi、Kusumoto Masahiko
- Journal Title
  
  JTO Clinical and Research Reports
  
  Volume: 3 Issue: 2 Pages: 100273-100273
- DOI
  10.1016/j.jtocrr.2021.100273
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07036, KAKENHI-PROJECT-21K06900
[Journal Article] Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer2022
- Author(s)
  Shirasawa Masayuki、Yoshida Tatsuya、Imabayashi Tatsuya、Okuma Kae、Matsumoto Yuji、Masuda Ken、Shinno Yuki、Okuma Yusuke、Goto Yasushi、Horinouchi Hidehito、Tsuchida Takaaki、Yamamoto Noboru、Nakayama Yuko、Watanabe Shun-ichi、Motoi Noriko、Ohe Yuichiro
- Journal Title
  
  European Journal of Cancer
  
  Volume: 162 Pages: 1-10
- DOI
  10.1016/j.ejca.2021.11.013
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07036, KAKENHI-PROJECT-21K06900
[Journal Article] Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC2021
- Author(s)
  Shirasawa Masayuki、Yoshida Tatsuya、Shimoda Yukiko、Takayanagi Daisuke、Shiraishi Kouya、Kubo Takashi、Mitani Sachiyo、Matsumoto Yuji、Masuda Ken、Shinno Yuki、Okuma Yusuke、Goto Yasushi、Horinouchi Hidehito、et al. and Motoi Noriko
- Journal Title
  
  Journal of Thoracic Oncology
  
  Volume: 16 Issue: 12 Pages: 2078-2090
- DOI
  10.1016/j.jtho.2021.07.027
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07036, KAKENHI-PROJECT-20H03695, KAKENHI-PROJECT-21K19492, KAKENHI-PROJECT-21K15584
[Journal Article] Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab2021
- Author(s)
  Jo Hitomi、Yoshida Tatsuya、Horinouchi Hidehito、Yagishita Shigehiro、Matsumoto Yuji、Shinno Yuki、Okuma Yusuke、Goto Yasushi、Yamamoto Noboru、Takahashi Kazuhisa、Motoi Noriko、Ohe Yuichiro
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 71 Issue: 2 Pages: 387-398
- DOI
  10.1007/s00262-021-02997-2
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07036, KAKENHI-PROJECT-21K15584
[Journal Article] Standardized uptake value on (18)F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs.2016
- Author(s)
  Yoshida T, Tanaka H, Kuroda H, Shimizu J, Horio Y, Sakao Y, Inaba Y, Iwata H, Hida T, Yatabe Y.
- Journal Title
  
  Lung Cancer
  
  Volume: 100 Pages: 14-19
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K19159
[Journal Article] 1.Clinical impact of crizotinib on central nervous system progression in ALK-positive non-small lung cancer.2016
- Author(s)
  Tatsuya　Yoshida
- Journal Title
  
  Lung Cancer
  
  Volume: 1 Pages: 1-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K19159
[Journal Article] Clinical impact of crizotinib on central nervous system progression in ALK-positive non-small lung cancer.2016
- Author(s)
  Yoshida T, Oya Y, Tanaka K, Shimizu J, Horio Y, Kuroda H, Sakao Y, Hida T, Yatabe Y.
- Journal Title
  
  Ｌｕｎｇ　Ｃancer
  
  Volume: 97 Pages: 43-47
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K19159
[Journal Article] 3.Rapid and dramatic response to alectinib in an ALK rearranged non-small-cell lung cancer patient who is critically ill.2016
- Author(s)
  Tatsuya　Yoshida
- Journal Title
  
  Anticancer Drugs.
  
  Volume: 1 Pages: 1-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K19159
[Journal Article] A phase II trial of prophylactic olanzapine combined with palonosetron and dexamethasone for preventing nausea and vomiting induced by cisplatin.2016
- Author(s)
  Maeda A, Ura T, Asano C, Haｓegawa I, Nomura M, Komori A, Narita Y, Taniguchi H, Kadowaki S, Muro K, Horio Y, Yoshida T, Oze I, Kajita M, Mizutani A.
- Journal Title
  
  Asia Pac J Clin Oncol.
  
  Volume: 12 Pages: 254-258
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K19159
[Journal Article] Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non-Small-Cell Lung Cancer.2016
- Author(s)
  Yoshida T, Oya Y, Tanaka K, Shimizu J, Horio Y, Kuroda H, Sakao Y, Hida T, Yatabe Y.
- Journal Title
  
  Journal of Clinical Oncology
  
  Volume: 34 Pages: 3383-3389
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K19159
[Journal Article] 2.RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutation.2015
- Author(s)
  Tatsuya　Yoshida
- Journal Title
  
  Lung Cancer
  
  Volume: 90 Issue: 3 Pages: 477-483
- DOI
  10.1016/j.lungcan.2015.09.025
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K19159, KAKENHI-INTERNATIONAL-15K21716, KAKENHI-PLANNED-26108007
[Presentation] 進行期非小細胞肺癌患者において腫瘍遺伝子変異ががん悪液質発症に及ぼす影響2023
- Author(s)
  藤井　博之、吉田　達哉、大江　裕一郎ほか
- Organizer
  第20回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-21K15584
[Presentation] Drug response prediction using deep neural network trained by adaptive resampling of histopathological images2022
- Author(s)
  Kiyuna, Tomoharu, Noriko Motoi, Hiroshi Yoshida, Hidehito Horinouchi, Tatsuya Yoshida, Takashi Kohno, Shun-ichi Watanabe, Yuichiro Ohe, and Atsushi Ochiai
- Organizer
  SPIE Medical Imaging
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K06900
[Presentation] 神経内分泌腫瘍の診断と治療　進行/再発肺大細胞神経内分泌癌における,Pd-1阻害剤の効果と腫瘍免疫微小環境との関連についての検討,2021
- Author(s)
  白澤昌之, 吉田達哉, 関根克敏, 神田慎太郎, 松元祐司, 増田健, 新野祐樹, 大熊裕介, 後藤悌, 堀之内秀仁, 山本昇, 渡辺俊一, 元井紀子, 大江裕一郎.
- Organizer
  第62回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-21K06900
[Presentation] 進行期NSCLCにおける悪液質の病態およびPembrolizumab治療効果の関係2021
- Author(s)
  徐仁美, 吉田達哉, 柳下薫寛, 堀之内秀仁, 松元祐司, 新野祐樹, 大熊裕介, 後藤悌, 山本昇, 元井紀子, 大江裕一郎
- Organizer
  第62回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-21K06900
[Presentation] 胸膜中皮腫における免疫チェックポイント阻害剤の位置づけと今後の治療戦略2021
- Author(s)
  吉田　達哉
- Organizer
  第62回日本肺癌学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-21K15584
[Presentation] 進行期 NSCLC における悪液質の病態および Pembrolizumab 治療効果の関係2021
- Author(s)
  徐　仁美、吉田　達哉
- Organizer
  第62回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-21K15584
[Presentation] 進行肺癌患者の就労を阻害する要因と支援の検討2017
- Author(s)
  吉川　惠、吉田　達哉、大矢　由子、山田　知里、永田　智子
- Organizer
  第31回日本がん看護学会学術集会
- Place of Presentation
  高知県立県民文化ホール（高知市）
- Year and Date
  2017-02-04
- Data Source
  KAKENHI-PROJECT-15K19159
[Presentation] The impact of crizotinib on brain metastasis in ALK-positive NSCLC patients2015
- Author(s)
  Tatsuya Yoshida
- Organizer
  日本臨床腫瘍学会
- Place of Presentation
  札幌
- Year and Date
  2015-07-16
- Data Source
  KAKENHI-PROJECT-15K19159
[Presentation] Impact of total lesion glycolysis at pretreatment FDG PET/CT on response duration of EGFR-TKIs2015
- Author(s)
  Tatsuya Yoshida
- Organizer
  European Cancer Congress
- Place of Presentation
  オーストリア　ウィーン
- Year and Date
  2015-09-25
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K19159
[Presentation] Differential crizotinib response duration among ALK fusion variants in ALK-positive non-small cell lung cancer2015
- Author(s)
  Tatsuya Yoshida
- Organizer
  ESMO AISA 2015
- Place of Presentation
  シンガポール
- Year and Date
  2015-12-18
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K19159
[Presentation] Impact of alectinib on survival after crizotinib failure in ALK-positive NSCLC patients2015
- Author(s)
  Tatsuya Yoshida
- Organizer
  European Cancer Congress
- Place of Presentation
  オーストリア　ウィーン
- Year and Date
  2015-09-25
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K19159
[Presentation] EGFR-TKI獲得耐性後におけるT790M耐性遺伝子変異とFDG/PET-CT所見の関連性の検討2015
- Author(s)
  吉田　達哉
- Organizer
  日本肺癌学会総会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2015-11-26
- Data Source
  KAKENHI-PROJECT-15K19159

1. 白澤昌之 (40898996)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
2. 元井紀子 (70292878)

# of Collaborated Projects: 1 results

# of Collaborated Products: 12 results
3. 石井源一郎 (00270869)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 大江裕一郎 (20233041)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
5. 田丸淳一 (30188429)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 青木一教 (60270675)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
7. 吉田裕 (70750751)

# of Collaborated Projects: 1 results

# of Collaborated Products: 8 results
8. 河野隆志 (80280783)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
9. 渡辺俊一 (80303303)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
10. 浜本隆二 (80321800)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 神田浩明 (90260067)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
12. 清水俊雄 (30411599)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 小山隆文 (30828538)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 勝屋友幾 (40752704)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 渡邊慶介 (60847466)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. 山本昇 (80501874)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. 洪泰浩 (80426519)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
18. 白石航也 (80609719)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
19. 柳下薫寛 (80781674)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. 坂下信悟

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Yoshida Tatsuya 吉田 達哉

吉田 達哉 ヨシダ タツヤ

Research Projects

Research Products

Co-Researchers

SCLC subtyping as a predictor of therapeutic response to immunotherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

進行癌に対する次世代抗体薬投与時サイトカインプロファイル緊急網羅的解析モデル探索

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development study on pathological predictive biomarkers for cancer treatment

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Acute phase protein and cachexia on adaptive immunity in thoracic malignancyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

進行期肺癌患者の就労支援、およびその阻害因子の同定に関する研究Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] An algorithm-based technique for counting mitochondria in cells using immunohistochemical staining of formalin-fixed and paraffin-embedded sections2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth: A Proposal by the International Association for the Study of Lung Cancer Pathology Committee2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prognostic role of modified Glasgow Prognostic score in elderly non-small cell lung cancer patients treated with anti-PD-1 antibodies2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical Characteristics and Pharmacokinetics Change of Long-Term Responders to Antiprogrammed Cell Death Protein 1 Inhibitor Among Patients With Advanced NSCLC2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma2023

Author(s)

Journal Title

DOI

Data Source

Yoshida Tatsuya 吉田達哉

吉田達哉ヨシダタツヤ